Wuhan Hiteck Biological Pharma Co Ltd (300683) — Strategic Asset Allocation Index
Wuhan Hiteck Biological Pharma Co Ltd (300683) has a Strategic Asset Allocation Index of 26.4% as of June 2023. Strategic assets (PP&E of CN¥688.19 Million plus long-term investments of CN¥-) total CN¥688.19 Million, measured against net assets of CN¥2.61 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Wuhan Hiteck Biological Pharma Co Ltd Strategic Asset Allocation Index (2016–2022)
This chart shows how Wuhan Hiteck Biological Pharma Co Ltd's Strategic Asset Allocation Index has evolved across 7 annual periods from 2016 to 2022. As of June 2023, the index stands at 26.4%, representing strategic assets of CN¥688.19 Million against net assets of CN¥2.61 Billion CNY. Explore 300683 operating cash flow to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Wuhan Hiteck Biological Pharma Co Ltd (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Wuhan Hiteck Biological Pharma Co Ltd from 2016 to 2022, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Wuhan Hiteck Biological Pharma Co Ltd market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 28.0% | CN¥654.23 Million | CN¥654.23 Million | CN¥- | CN¥2.34 Billion | ▲ +5.8 pp |
| 2021 | 22.2% | CN¥519.63 Million | CN¥519.63 Million | CN¥- | CN¥2.34 Billion | ▲ +2.0 pp |
| 2020 | 20.2% | CN¥348.63 Million | CN¥348.63 Million | CN¥- | CN¥1.72 Billion | ▲ +4.6 pp |
| 2019 | 15.6% | CN¥274.33 Million | CN¥274.33 Million | CN¥- | CN¥1.76 Billion | ▲ +2.3 pp |
| 2018 | 13.2% | CN¥226.44 Million | CN¥226.44 Million | CN¥- | CN¥1.71 Billion | ▲ +6.4 pp |
| 2017 | 6.8% | CN¥112.09 Million | CN¥112.09 Million | CN¥- | CN¥1.64 Billion | ▼ -7.8 pp |
| 2016 | 14.6% | CN¥102.99 Million | CN¥102.99 Million | CN¥- | CN¥703.35 Million | — |